Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million
Hand-out
Press Releases
Novavax, Inc., Novo Nordisk  
December 4, 2024

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million

Agreement provides significant, non-dilutive capital to Novavax, further enabling the Company to advance its corporate growth strategy of driving value from its pipeline assets and proven technology platformProvides Novavax with

logo salamanca press

Salamanca Press

Local & Social